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Background and aim: Knowledge of the impact of social determinants driving asthma–
chronic obstructive pulmonary disease overlap (ACO) is lacking. Our objective was to identify 
determinants of incident ACO.
Methods: A total of 55,053 adults (50–64 years) enrolled in the Danish Diet, Cancer, and 
Health cohort (1993–97) was followed in the National Patient Registry for admissions for 
asthma (DJ45–46) and chronic obstructive pulmonary disease (COPD; DJ40–44) and vital 
status. Incident ACO was defined as at least one hospital admission for both asthma and COPD 
(different time points, one after baseline). Detailed case history was obtained at baseline. Cox 
proportional hazards model was used to examine associations between possible determinants 
and incident ACO, in terms of hazard ratio (HR) and 95% confidence interval (CI).
Results: During follow-up, 561 incident cases of ACO were identified. Age (HR 4.4, 95% CI 
3.3–5.9, age group 60–65 years), current smoking (HR 3.6, 95% CI 2.8–4.6), unemployment 
(HR 1.5, 95% CI 1.2–1.8), and being divorced (HR 1.5, 95% CI 1.2–1.9) determined a higher 
risk of incident ACO, whereas the opposite was found for leisure-time physical activity (HR 
0.7, 95% CI 0.6–0.8) and high educational level (HR 0.7, 95% CI 0.5–0.9). In contrast to ACO, 
preexisting myocardial infarction (MI; HR 1.5, 95% CI 1.2–1.8) and stroke (HR 1.5, 95% CI 
1.2–1.9) were associated with a higher risk of COPD.
Conclusion: Incident ACO is to a large extent determined by factors related to lifestyle and 
socioeconomic status.
Keywords: asthma–COPD overlap, socioeconomic status, lifestyle
Introduction
Asthma and chronic obstructive pulmonary disease (COPD) have been regarded 
as distinct disease entities for decades. Asthma usually develops early in life and is 
characterized by episodes of reversible airflow limitation accompanied by typical 
respiratory symptoms, including wheeze,1 whereas COPD develops later in life and is 
characterized by persistent airflow limitation and excessive decline in lung function.2 
Although classic asthma and COPD are easily distinguished, patients often present with 
overlapping features, especially among elderly patients as they may exhibit atypical 
symptoms and may also have altered perception of their symptoms, and in line with 
this, smoking history is not a clear-cut feature to distinguish asthma from COPD as a 
substantial proportion of patients with asthma are current or ex-smokers. Furthermore, 
the structural changes in the aging lung are associated with some degree of persistent 
airflow limitation, which may account for loss of bronchodilator reversibility in patients 
with underlying asthma and not COPD.3–5 
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To describe this coexistence of features of asthma and 
COPD, the term asthma–COPD overlap syndrome (ACOS) 
was introduced,6 which has been increasingly recognized in 
recent years’ literature.7–9 In line with this, the 2014 Global 
Initiative for Asthma–Global Initiative for Chronic Obstruc-
tive Lung Disease (GINA–GOLD) document suggests that 
patients with ACOS should be regarded as a subgroup of 
patients with obstructive lung diseases.10 However, more 
recently, the introduction of the widely accepted umbrella 
term asthma–COPD overlap (ACO) reflects that this coexis-
tence of asthma and COPD features are unlikely to represent 
a single discrete disease entity.9 
Previous studies have shown that individuals with ACO 
show more symptoms, worse quality of life, more frequent 
exacerbations, increased use of health care resources, more 
hospitalizations and a higher mortality compared to those 
who have asthma or COPD alone.8,9,11–13 However, further 
knowledge regarding the biology and pathophysiology of 
patients with ACO is clearly needed, also in relation to man-
agement strategy. In the very recently published American 
Thoracic Society/National Heart, Lung and Blood Institute 
Asthma–Chronic Obstructive Pulmonary Disease Overlap 
Workshop Report, it is stated that in future studies, it will 
be of outmost importance to address the effects of social 
determinants of health in driving asthma, COPD and ACO.9 
The aim of this large population-based cohort study was 
to identify determinants of incident ACO compared to those 
of asthma and COPD alone.
Methods
Danish Diet, Cancer, and health (DCh) 
cohort
We used the DCH cohort consisting of 57,053 individu-
als aged 50–64 years who were born in Denmark, lived in 
Copenhagen or Aarhus and were cancer free at baseline 
(1993–1997).14 All participants answered a detailed self-
administered questionnaire on dietary habits, education, 
occupational history, lifestyle (smoking, physical activ-
ity, alcohol use), marital status, hormone replacement 
therapy (HRT) use, and preexisting conditions, including 
asthma, COPD, diabetes, myocardial infarction (MI), and 
stroke, and provided height and weight measurements. A 
detailed description of the DCH cohort has been published 
previously.14,15
Exposure definition
Tobacco exposure was calculated by equating a cigarette to 
1 g, a cheroot or a pipe to 3 g, and a cigar to 5 g of tobacco 
and reported as daily tobacco consumption and years of 
smoking. Environmental tobacco smoke (ETS) was included 
as an indicator of exposure to second-hand smoke at home 
or work for minimum 4 hours/day. Occupational exposure 
relevant for chronic lung disease was defined as a minimum 
of 1 year’s employment in mining; in electroplating; in shoe 
or leather manufacturing; in welding; in painting; in steel 
mill or shipyard; in construction (roof, asphalt, or demoli-
tion); as a truck, bus, or taxi driver; in asbestos or cement 
manufacturing; in asbestos insulation; in glass, china, or 
pottery manufacturing; as a butcher; as a auto mechanic; as 
a waiter; or as a cook.
Definitions of health outcome
By using the unique identification number assigned to all 
Danish citizens (Danish Personal Identification Number),16 
the DCH cohort was linked to the Danish National Patient 
Registry (DNPR)17,18 to prospectively extract hospital con-
tacts from 1978 until July 1, 2013. DNPR includes all dis-
charge diagnoses from all Danish hospitals since 1978 and 
from outpatient clinics since 1995.18 All registered hospital 
contacts were included in the present analyses: admissions, 
outpatient clinic visits, and emergency room visits. Unless 
otherwise specified, admission refers to all three types of 
contacts. COPD and asthma diagnoses were classified accord-
ing to the International Classification of Diseases (ICD) as 
ICD-10 codes DJ40–44 (and 490.0–492.09 according to 
ICD-8 until 1994) and ICD-10 codes DJ45–46 (and ICD-8 
codes 493.00–493.09), respectively, as ICD-9 was never 
implemented in Denmark. To allow for variations in clas-
sification procedures, patients with a primary diagnosis of 
DJ960 (acute respiratory failure) were also included, provided 
they had a secondary diagnosis of asthma or COPD. First 
hospital contacts after baseline (1993–1997) for asthma and/
or COPD were classified as incident contacts.
Cohort participants were defined as having asthma if 
they, during the study period, exclusively had admissions for 
asthma, and the same was applicable for participants with 
COPD. Participants were defined as having ACO if they had 
at least one admission for asthma and at least one admission 
for COPD (at two different time points, regardless of which 
came first), as described previously.11 Participants were clas-
sified as having ACO at baseline if they had had at least one 
admission for asthma and also at least one admission for 
COPD before enrolment into the cohort. Incident ACO was 
thus defined as at least one first-time admission for either 
asthma or COPD occurring after baseline (1993–1997), 
with date of earliest admission as date of ACO onset. In line 
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with this, participants classified as having asthma alone and 
COPD alone, respectively, were further divided into prevalent 
at baseline (first admission before 1993–1997) and incident 
(first admission after baseline). In the present analyses, only 
incident cases of ACO, asthma, and COPD were included 
(Figure 1).
statistical analyses and ethics
We used Cox proportional hazards model with age as underly-
ing time scale to examine the associations between a number 
of possible determinants of ACO: age, sex, active and passive 
smoking, occupational exposures, body mass index (BMI), 
leisure-time physical activity, fruit intake, education, employ-
ment status, civil status, and comorbidities (defined and listed 
in Tables 1–3) with ACO, asthma, and COPD, respectively, 
in three separate models. Follow-up started on the date of 
recruitment into the cohort (1993–1997) and ended at the 
date of first ACO, asthma, or COPD admission; date of death; 
date of emigration; or July 1, 2013, whichever came first. We 
evaluated the effect of each possible determinant in three 
steps: first, in a univariate model, adjusted for age (underly-
ing time scale) (Model 1); second, in a fully adjusted model, 
with all variables included (Model 2); and in the final model, 
we included only variables that were statistically signifi-
cantly associated with ACO, COPD, or asthma in the second 
model and performed a backward elimination (Model 3). 
We checked the proportional hazards assumption by testing 
for a nonzero slope in a generalized linear regression of the 
scaled Schoenfeld residuals on functions of time.19 Results 
are presented as hazard ratios (HRs) with 95% confidence 
intervals (CIs), estimated with stcox in Stata 11.2. The DCH 
cohort study was approved by the Central Danish Ethics 
 Committee, and the present study was approved by the Danish 
Data Protection Agency (2014-41-3468). All participants in 
the DCH cohort provided written informed consent.
Results
Cohort
Of the 57,053 individuals enrolled in the cohort, we excluded 
571 with cancer diagnoses before baseline, 70 with ACO 
before baseline, and 1,236 with missing information on 
covariates. The final cohort included in the present analysis, 
therefore, comprised 55,110 individuals.
Characteristics of participants with 
incident aCO
Among the 55,110 individuals without ACO at baseline, 561 
(1.0%) of the cohort incident cases of ACO were observed 
during the mean follow-up period of 16 years, corresponding 
to 884,925 person-years, with an incidence rate of 63 cases 
per 100,000 person-years. At baseline, individuals classified 
as having ACO were less likely to be never smokers, physi-
cally active in leisure time, have ≥10 years of education, and 
to be married compared to the remaining cohort, whereas they 
were more likely to have cardiovascular comorbidity and to 
have been on postmenopausal HRT (Table 1).
Characteristics of participants with 
incident COPD
In analyses of incident COPD, we excluded 352 subjects with 
hospital admissions for COPD before baseline and 272 with 
missing information on covariates. Of the remaining 54,829 
individuals without COPD at the baseline, 2,886 (5.3%) had 
a first-ever hospital admission for COPD during the mean 
Figure 1 Graphical illustration of the definitions of prevalent and incident ACO according to time of first admission for asthma and COPD.
Note: Only incident cases of aCO are included in the analyses.
Abbreviations: aCO, asthma–chronic obstructive pulmonary disease overlap; COPD, chronic obstructive pulmonary disease.
Baseline 1993–1997
Prevalent ACO
Asthma
Asthma
Asthma
Asthma
Asthma
Asthma
Incident ACO
COPD
COPD
COPD
COPD
COPD
COPD
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follow-up period of 15.8 years or 868,424 person-years, cor-
responding to an incidence rate of 332 per 100,000 person-
years. Among incident COPD cases, the majority (77.4%) 
were smokers at baseline (Table 2).
Characteristics of participants with 
incident asthma
In analyses of incident asthma, we excluded 363 persons with 
hospital admissions for asthma before baseline and 261 with 
missing information on covariates. Of the remaining 54,829 
participants without asthma at the baseline, 785 (1.4%) were 
admitted to hospital for asthma for the first time during the 
Table 1 Characteristics of participants (n=55,110) enrolled in the DCh cohort (1993–1997) according to aCO status at the time of 
follow-up (2013)
Characteristics Total (N=55,110) Without ACO 
(n=54,549)
ACO (n=561)
age (years), mean (sD) 56.7 (4.4) 56.7 (4.4) 58.2 (4.4)
50–54, n (%) 23,317 (42.3) 23,159 (42.5) 158 (28.2)
55–59, n (%) 17,060 (31.0) 16,884 (31.0) 176 (31.4)
60–65, n (%) 14,703 (26.7) 14,476 (26.6) 227 (40.5)
Males, n (%) 26,240 (47.6) 26,017 (47.7) 223 (39.8)
never smoked, n (%) 19,486 (35.4) 19,402 (35.6) 84 (15.0)
Previously smoked, n (%) 15,795 (28.7) 15,647 (28.7) 148 (26.4)
Currently smoke, n (%) 19,829 (36.0) 19,500 (35.7) 329 (58.6)
smoking duration (years), mean (sD) 29.3 (12.3) 29.3 (12.3) 34.6 (10.1)
smoking intensity (g/day), mean (sD) 9.7 (11.6) 9.7 (11.6) 11.7 (10.5)
ETs, n (%) 35,361 (64.2) 34,909 (64.0) 452 (80.6)
Occupational exposure, n (%) 13,379 (24.3) 13,215 (24.2) 164 (29.2)
BMi (kg/m2), mean (sD) 26.0 (4.1) 26.0 (4.0) 26.1 (4.7)
Underweight (<18.5 kg/m2), n (%) 425 (0.8) 414 (0.8) 11 (2.0)
normal (18.5–25 kg/m2), n (%) 23,710 (43.0) 23,478 (43.0) 232 (41.4)
Overweight (25–30 kg/m2), n (%) 22,985 (41.7) 22,762 (41.7) 223 (39.8)
Obese (≥30 kg/m2), n (%) 7,990 (14.5) 7,895 (14.5) 95 (16.9)
Physically active in leisure time, n (%) 29,729 (53.9) 29,508 (54.1) 221 (39.4)
Fruit intake (g/day), mean (sD) 181.7 (149.7) 181.8 (149.6) 176.6 (159.4)
Ever hrT user, n (%) 12,688 (23.0) 12,504 (22.9) 184 (32.8)
<8 years of education, n (%) 18,109 (32.9) 17,859 (32.7) 250 (44.6)
8–10 years of education, n (%) 25,431 (46.1) 25,192 (46.2) 239 (42.6)
≥10 years of education, n (%) 11,570 (21.0) 11,498 (21.1) 72 (12.8)
Unemployed, n (%) 12,031 (21.8) 11,824 (21.7) 207 (36.9)
Unmarried, n (%) 3,284 (6.0) 3,260 (6.0) 24 (4.3)
Married, n (%) 39,470 (71.6) 39,129 (71.7) 341 (60.8)
Divorced, n (%) 9,314 (16.9) 9,173 (16.8) 141 (25.1)
Widowed, n (%) 3,042 (5.5) 2,987 (5.5) 55 (9.8)
asthma before baseline, n (%) 352 (0.6) 352 (0.6) 0 (0.0)
COPD before baseline, n (%) 343 (0.6) 343 (0.6) 0 (0.0)
Comorbid conditions
Mi, n (%) 1,152 (2.1) 1,135 (2.1) 17 (3.0)
stroke, n (%) 734 (1.3) 721 (1.3) 13 (2.3)
Diabetes, n (%) 1,138 (2.1) 1,123 (2.1) 15 (2.7)
hypertension, n (%) 9,010 (16.3) 8,907 (16.3) 103 (18.4)
hypercholesterolemia, n (%) 4,120 (7.5) 4,082 (7.5) 38 (6.8)
Note: Asthma-COPD overlap defined as admissions for both asthma and COPD, at two different time points.
Abbreviations: DCh, Danish Diet, Cancer, and health; aCO, asthma–chronic obstructive pulmonary disease overlap; ETs, environmental tobacco smoke; BMi, body mass 
index; COPD, chronic obstructive pulmonary disease; Mi, myocardial infarction; hrT, hormone replacement therapy.
mean follow-up period of 16 years or 875,333 person-years, 
corresponding to an incidence rate of 90 cases per 100,000 
person-years. At baseline, more women with incident asthma 
reported use of HRT than participants without asthma 
(Table 3). A comparison of participants with incident ACO, 
COPD, and asthma is given in Table 4.
Determinants of incident aCO compared 
to asthma and COPD alone
Details of the stepwise analysis of determinants of incident 
ACO during the observation period are given in Table 5. Age 
(HR 4.41, 95% CI 3.33–5.85, for age group 60–65 years 
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Table 2 Characteristics of the 54,829 individuals without COPD at baseline (1993–1997) enrolled in the DCh cohort according to 
COPD status at the end of follow-up (2013)
Characteristics Total 
(N=54,829)
Without COPD 
(n=51,943)
COPD (n=2,886)
age (years), mean (sD) 56.7 (4.4) 56.6 (4.3) 58.1 (4.4)
50–54, n (%) 23,231 (42.4) 22,370 (43.1) 861 (29.8)
55–59, n (%) 16,965 (31.0) 16,064 (30.9) 901 (31.2)
60–65, n (%) 14,603 (26.6) 13,480 (26.0) 1,123 (38.9)
Males, n (%) 26,092 (47.6) 24,755 (47.7) 1,337 (46.3)
never smoked, n (%) 19,464 (35.5) 19,290 (37.1) 174 (6.0)
Previously smoked, n (%) 15,734 (28.7) 15,256 (29.4) 478 (16.6)
Currently smoke, n (%) 19,631 (35.8) 17,397 (33.5) 2,234 (77.4)
smoking duration (years), mean (sD) 29.3 (12.3) 28.7 (12.4) 37.2 (8.6)
smoking intensity (g/day), mean (sD) 9.7 (11.6) 9.2 (11.5) 15.9 (11.8)
ETs, n (%) 35,118 (64.1) 32,561 (62.7) 2,557 (88.6)
Occupational exposure, n (%) 13,251 (24.2) 12,253 (23.6) 998 (34.6)
BMi (kg/m2), mean (sD) 417 (0.8) 26.1 (4.0) 25.7 (4.5)
Underweight (<18.5 kg/m2) 417 (0.8) 354 (0.7) 63 (2.2)
normal (18.5–25 kg/m2) 23,596 (43.0) 22,270 (42.9) 1,326 (45.9)
Overweight (25–30 kg/m2) 22,870 (41.7) 21,820 (42.0) 1,050 (36.4)
Obese (≥30 kg/m2) 7,946 (14.5) 7,499 (14.4) 447 (15.5)
Physically active in leisure time, n (%) 29,636 (54.1) 28,469 (54.8) 1,167 (40.4)
Fruit intake (g/day), mean (sD) 181.9 (149.8) 183.5 (150.0) 153.4 (144.1)
Ever hrT user, n (%) 12,618 (23.0) 11,795 (22.7) 823 (28.5)
<8 years of education, n (%) 17,951 (32.7) 16,593 (31.9) 1,358 (47.1)
8–10 years of education, n (%) 25,324 (46.2) 24,171 (46.5) 1,153 (40.0)
≥10 years of education, n (%) 11,554 (21.1) 11,179 (21.5) 375 (13.0)
Unemployed, n (%) 11,927 (21.8) 10,910 (21.0) 1,017 (35.2)
Unmarried, n (%) 3,273 (6.0) 16,593 (31.9) 1,358 (47.1)
Married, n (%) 39,292 (71.7) 24,171 (46.5) 1,153 (40.0)
Divorced, n (%) 9,245 (16.9) 11,179 (21.5) 375 (13.0)
Widowed, n (%) 3,019 (5.5) 16,593 (31.9) 1,358 (47.1)
aCO before baseline, n (%) 62 (0.1) 62 (0.1) 0 (0.0)
COPD before baseline, n (%) 352 (0.6) 352 (0.7) 0 (0.0)
Comorbid conditions
Mi, n (%) 1,140 (2.1) 1,027 (2.0) 113 (3.9)
stroke, n (%) 724 (1.3) 641 (1.2) 83 (2.9)
Diabetes, n (%) 1,131 (2.1) 1,066 (2.1) 65 (2.3)
hypertension, n (%) 8,964 (16.3) 8,446 (16.3) 518 (17.9)
hypercholesterolemia, n (%) 4,099 (7.5) 3,829 (7.4) 270 (9.4)
Abbreviations: COPD, chronic obstructive pulmonary disease; DCh, Danish Diet, Cancer, and health; ETs, environmental tobacco smoke; BMi, body mass index; aCO, 
asthma–chronic obstructive pulmonary disease overlap; Mi, myocardial infarction; hrT, hormone replacement therapy.
compared to 50–55 years), current smoking (HR 3.59, 95% 
CI 2.81–4.59), ever use of HRT (women only; HR 1.37, 95% 
CI 1.11–1.70), unemployment (HR 1.48, 95% CI 1.23–1.79), 
and being divorced (HR 1.52, 95% CI 1.24–1.85) at baseline 
were associated with a statistically significant higher risk of 
ACO. On the other hand, physical activity in leisure time (HR 
0.66, 95% CI 0.55–0.78) and high education (≥10 years; HR 
0.67, 95% CI 0.51–0.87) were associated with a lower risk 
of ACO. No association was found between overweight or 
obesity, ETS, or comorbidity with MI, stroke, or diabetes at 
baseline and ACO. Notably, underweight was associated with 
an increased risk of ACO compared to overweight (HR 1.76, 
95% CI 0.96–3.24), although statistically nonsignificant.
In contrast to ACO, preexisting MI (HR 1.48, 95% CI 
1.23–1.80), stroke (HR 1.54, 95% CI 1.23–1.92), ETS (HR 
1.21, 95% CI 1.15–1.23), and occupational exposure (HR 
1.29, 95% CI 1.18–1.41) were associated with a higher risk 
of COPD (Table 6). Furthermore, in contrast to ACO and 
COPD, asthma risk was increased by obesity (HR 1.52, 95% 
CI 1.24–1.86) and high education level (≥10 years; HR 1.24, 
95% CI 1.02–1.52; Table 7). Comparing incident ACO only to 
participants with at least two admissions for asthma or COPD, 
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Table 3 Characteristics of the 54,820 individuals without asthma at baseline (1993–1997) enrolled in the DCh cohort according to 
asthma status at the end of follow-up (2013)
Characteristics Total 
(n=54,820)
Without asthma 
(n=54,035)
Asthma 
(n=785)
age (years), mean (sD) 56.7 (4.4) 56.7 (4.4) 56.5 (4.4)
50–54, n (%) 23,188 (42.3) 22,840 (42.3) 348 (44.3)
55–59, n (%) 16,963 (31.0) 16,728 (31.0) 235 (29.9)
60–65, n (%) 14,639 (26.7) 14,437 (26.7) 202 (25.7)
Males, n (%) 26,133 (47.7) 28,192 (52.2) 495 (63.1)
never smoked, n (%) 19,347 (35.3) 18,996 (35.2) 351 (44.7)
Previously smoked, n (%) 15,686 (28.6) 15,426 (28.5) 260 (33.1)
Currently smoke, n (%) 19,787 (36.1) 19,613 (36.3) 174 (22.2)
smoking duration (years), mean (sD) 29.4 (12.3) 29.4 (12.3) 25.9(11.8)
smoking intensity (g/day), mean (sD) 9.8 (11.6) 9.8 (11.7) 5.7 (9.1)
ETs, n (%) 35,195 (64.2) 34,746 (64.3) 449 (57.2)
Occupational exposure, n (%) 13,315 (24.3) 13,151 (24.3) 164 (20.9)
BMi (kg/m2), mean (sD) 26.0 (4.1) 26.0 (4.0) 26.5 (4.2)
Underweight (<18.5 kg/m2), n (%) 425 (0.8) 421 (0.8) 4 (0.5)
normal (18.5–25 kg/m2), n (%) 23,591 (43.0) 23,282 (43.1) 309 (39.4)
Overweight (25–30 kg/m2), n (%) 22,874 (41.7) 22,541 (41.7) 333 (42.4)
Obese (≥30 kg/m2), n (%) 7,930 (14.5) 7,791 (14.4) 139 (17.7)
Physically active in leisure time, n (%) 29,549 (53.9) 29,117 (53.9) 432 (55.0)
Fruit intake (g/day), mean (sD) 181.5 (149.6) 181.4 (149.7) 191.8 (144.8)
Ever hrT user, n (%) 12,605 (23.0) 12,340 (22.8) 265 (33.8)
<8 years of education, n (%) 18,013 (32.9) 17,790 (32.9) 223 (28.4)
8–10 years of education, n (%) 25,305 (46.2) 24,910 (46.1) 395 (50.3)
≥10 years of education, n (%) 11,502 (21.0) 11,335 (21.0) 167 (21.3)
Unemployed, n (%) 11,966 (21.8) 11,793 (21.8) 173 (22.0)
Unmarried, n (%) 3,267 (6.0) 3,222 (6.0) 45 (5.7)
Married, n (%) 39,259 (71.6) 38,701 (71.6) 558 (71.1)
Divorced, n (%) 9,266 (16.9) 9,130 (16.9) 136 (17.3)
Widowed, n (%) 3,028 (5.5) 2,982 (5.5) 46 (5.9)
aCO before baseline, n (%) 66 (0.1) 66 (0.1) 0 (0.0)
COPD before baseline, n (%) 343 (0.6) 343 (0.6) 0 (0.0)
Comorbid conditions
Mi, n (%) 1,152 (2.1) 1,139 (2.1) 13 (1.7)
stroke, n (%) 734 (1.3) 730 (1.4) 4 (0.5)
Diabetes, n (%) 1,134 (2.1) 1,121 (2.1) 13 (1.7)
hypertension, n (%) 8,955 (16.3) 8,800 (16.3) 155 (19.7)
hypercholesterolemia, n (%) 4,106 (7.5) 4,060 (7.5) 46 (5.9)
Abbreviations: DCh, Danish Diet, Cancer, and health; ETs, environmental tobacco smoke; BMi, body mass index; aCO, asthma–chronic obstructive pulmonary disease 
overlap; COPD, chronic obstructive pulmonary disease; Mi, myocardial infarction; hrT, hormone replacement therapy.
respectively, did not substantially change the observations. A 
more detailed description of determinants for incident ACO, 
COPD, and asthma is given in Table 8.
Discussion
This prospective study of a large population-based cohort of 
middle-aged adults revealed that incident asthma–COPD is 
to a large extent determined by factors related to lifestyle, 
including currently smoking, being unemployed, marital 
status, and leisure-time physical activity, and socioeconomic 
status, including level of education.
Characteristics of participants with aCO 
compared to asthma and COPD only
As might have been expected, the proportion of ever-smokers 
in the ACO group was found to be in between that of par-
ticipants with asthma and COPD only, as has been shown 
in previous studies.20–22 The proportion of participants with 
≥10 years of education was similar for participants with 
ACO and COPD (12.8% and 13.0%, respectively), whereas 
it was substantially higher for participants with asthma alone 
(21.3%). This confirms previous findings by Kumbhare et al21 
of 17.7%, 18.8%, and 34.9%, respectively, graduating from 
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Table 4 Characteristics of participants from the DCh cohort, with a status of incident asthma, COPD, or aCO at follow-up (2013)
Characteristics Asthma (n=785) COPD (n=2,886) ACO (n=561)
age (years), mean (sD) 56.5 (4.4) 58.1 (4.4) 58.2 (4.4)
50–54, n (%) 348 (44.3) 861 (29.8) 158 (28.2)
55–59, n (%) 235 (29.9) 901 (31.2) 176 (31.4)
60–65, n (%) 202 (25.7) 1,123 (38.9) 227 (40.5)
Men, n (%) 495 (63.1) 1,337 (46.3) 223 (39.8)
never smoked, n (%) 351 (44.7) 174 (6.0) 84 (15.0)
Previously smoked, n (%) 260 (33.1) 478 (16.6) 148 (26.4)
Currently smoke, n (%) 174 (22.2) 2,234 (77.4) 329 (58.6)
smoking duration (years), mean (sD) 25.9(11.8) 37.2 (8.6) 34.6 (10.1)
smoking intensity (g/day), mean (sD) 5.7 (9.1) 15.9 (11.8) 11.7 (10.5)
ETs, n (%) 449 (57.2) 2,557 (88.6) 452 (80.6)
Occupational exposure, n (%) 164 (20.9) 998 (34.6) 164 (29.2)
BMi (kg/m2), mean (sD) 26.5 (4.2) 25.7 (4.5) 26.1 (4.7)
Underweight (<18.5 kg/m2), n (%) 4 (0.5) 63 (2.2) 11 (2.0)
normal (18.5–25 kg/m2), n (%) 309 (39.4) 1,326 (45.9) 232 (41.4)
Overweight (25–30 kg/m2), n (%) 333 (42.4) 1,050 (36.4) 223 (39.8)
Obese (≥30 kg/m2), n (%) 139 (17.7) 447 (15.5) 95 (16.9)
Physically active in leisure time, n (%) 432 (55.0) 1,167 (40.4) 221 (39.4)
Fruit intake (g/day), mean (sD) 191.8 (144.8) 153.4 (144.1) 176.6 (159.4)
Ever hrT user, n (%) 265 (33.8) 823 (28.5) 184 (32.8)
<8 years of education, n (%) 223 (28.4) 1,358 (47.1) 250 (44.6)
8–10 years of education, n (%) 395 (50.3) 1,153 (40.0) 239 (42.6)
≥10 years of education, n (%) 167 (21.3) 375 (13.0) 72 (12.8)
Unemployed, n (%) 173 (22.0) 1,017 (35.2) 207 (36.9)
Unmarried, n (%) 45 (5.7) 1,358 (47.1) 24 (4.3)
Married, n (%) 558 (71.1) 1,153 (40.0) 341 (60.8)
Divorced, n (%) 136 (17.3) 375 (13.0) 141 (25.1)
Widowed, n (%) 46 (5.9) 1,358 (47.1) 55 (9.8)
asthma before baseline, n (%) 0 (0.0) 0 (0.0) 0 (0.0)
COPD before baseline, n (%) 0 (0.0) 0 (0.0) 0 (0.0)
Comorbid conditions
Mi, n (%) 13 (1.7) 113 (3.9) 17 (3.0)
stroke, n (%) 4 (0.5) 83 (2.9) 13 (2.3)
Diabetes, n (%) 13 (1.7) 65 (2.3) 15 (2.7)
hypertension, n (%) 155 (19.7) 518 (17.9) 103 (18.4)
hypercholesterolemia, n (%) 46 (5.9) 270 (9.4) 38 (6.8)
Abbreviations: DCh, Danish Diet, Cancer, and health; COPD, chronic obstructive pulmonary disease; aCO, asthma–chronic obstructive pulmonary disease overlap; ETs, 
environmental tobacco smoke; BMi, body mass index; Mi, myocardial infarction; hrT, hormone replacement therapy.
college in the ACO, COPD-only, and asthma-only groups. 
On the other hand, Kim et al20 found a more distinct separa-
tion between the three groups, as 9.7%, 17.7% and 25.9% of 
participants had >12 years of education in the ACO, COPD, 
and asthma groups, respectively, whereas Sorino et al22 found 
no difference between the three groups with regard to years 
of education. Although the varying definitions of education 
make it difficult to compare studies, these differences may 
also be influenced by different sampling of cohorts and diag-
nostic criteria. In the study by Kim et al,20 a similar cut point 
was used for level of education, but the cohort investigated 
was much younger than in the present study comparable to 
the study by Kumbhare et al,21 whereas the cohort studied by 
Sorino et al22 was similar to ours. Kumbhare et al21 conducted 
a telephone survey and defined ACO as self-reported ever-
diagnosed COPD and self-reported current asthma, whereas 
Kim et al20 performed a national survey of a representative 
selection of the population, measured lung function, and 
defined ACO as a FEV
1
/FVC ratio below lower limit of 
normal plus wheezing within the previous 12 months. On 
the other hand, Sorino et al22 performed a multicenter study 
of an elderly population, with several criteria for being clas-
sified as having ACO, based on lung function, bronchodila-
tor reversibility, wheezing, and atopy. So, although not all 
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Table 5 Determinants at baseline (1993–1997) of incident aCO at follow-up (2013) among 55,110 participants in the DCh cohort
Variables Model 1, HR (95% CI) Model 2, HR (95% CI) Model 3, HR (95% CI)
age 50–54 years 1.00 1.00 1.00
age 55–59 years 2.36 (1.85–3.03) 1.94 (1.51–2.49) 2.11 (1.65–2.71)
age 60–65 years 5.72 (4.37–7.49) 3.60 (2.68–4.82) 4.41 (3.33–5.85)
Female 1.00 1.00 1.00
Male 0.75 (0.63–0.88) 0.75 (0.60–0.95) 0.83 (0.67–1.03)
never smoked 1.00 1.00 1.00
Previously smoked 2.26 (1.73–2.95) 1.11 (0.75–1.63) 2.23 (1.70–2.92)
Currently smoke 4.12 (3.24–5.23) 1.21 (0.73–2.00) 3.59 (2.81–4.59)
smoking duration (per 10 years) 1.53 (1.45–1.62) 1.35 (1.20–1.51) –
smoking intensity (per 10 g/day) 1.29 (1.23–1.36) 0.96 (0.86–1.08) –
no ETs 1.00 1.00 –
Exposed to ETs 2.42 (1.97–2.99) 1.16 (0.91–1.48) –
no occupational exposure 1.00 1.00 –
had occupational exposure 1.32 (1.10–1.59) 1.12 (0.91–1.37) –
Underweight (<18.5 kg/m2) 2.93 (1.60–5.37) 1.68 (0.91–3.09) 1.76 (0.96–3.24)
normal (18.5–25 kg/m2) 1.00 1.00 1.00
Overweight (25–30 kg/m2) 1.00 (0.84–1.21) 1.03 (0.85–1.25) 1.04 (0.86–1.26)
Obese (≥30 kg/m2) 1.26 (0.99–1.59) 1.17 (0.91–1.51) 1.20 (0.94–1.54)
inactive in leisure time 1.00 1.00 1.00
Physically active in leisure time 0.53 (0.45–0.63) 0.67 (0.56–0.80) 0.66 (0.55–0.78)
Fruit intake (100 g/day), mean (sD) 0.97 (0.92–1.03) 1.03 (0.97–1.09) –
never used hrT 1.00 1.00 1.00
Ever used hrT 1.63 (1.36–1.94) 1.35 (1.09–1.68) 1.37 (1.11–1.70)
<8 years of education 1.00 1.00 1.00
8–10 years of education 0.65 (0.54–0.77) 0.89 (0.74–1.08) 0.84 (0.70–1.01)
≥10 years of education 0.42 (0.33–0.55) 0.74 (0.56–0.98) 0.67 (0.51–0.87)
Employed 1.00 1.00 1.00
Unemployed 2.49 (2.09–2.97) 1.42 (1.17–1.71) 1.48 (1.23–1.79)
not married 0.82 (0.54–1.24) 0.82 (0.54–1.24) 0.81 (0.53–1.22)
Married/partnership 1.00 1.00 1.00
Divorced 1.77 (1.45–2.15) 1.51 (1.23–1.84) 1.52 (1.24–1.85)
Widow 2.26 (1.70–3.01) 1.50 (1.12–2.01) 1.53 (1.14–2.05)
Comorbid conditions
no Mi 1.00 1.00 –
had Mi 1.79 (1.10–2.98) 1.15 (0.69–1.89) –
no stroke 1.00 1.00 –
had stroke 2.04 (1.18–3.54) 1.28 (0.73–2.24) –
no diabetes 1.00 1.00 –
Diabetes 1.48 (0.88–2.47) 1.16 (0.69–1.94) –
no hypertension 1.00 1.00 –
hypertension 1.21 (0.98–1.50) 1.09 (0.87–1.36) –
no hypercholesterolemia 1.00 1.00 –
hypercholesterolemia 0.95 (0.68–1.32) 0.75 (0.53–1.06) –
Notes: Model 1, univariate model; Model 2, fully adjusted model, with all variables in the model; Model 3, final model with determinants of ACO by stepwise selection 
(P<0.05). “–” indicates the variable not being included in model 3.
Abbreviations: ACO, asthma–chronic obstructive pulmonary disease overlap; DCH, Danish Diet, Cancer, and Health; HR, hazard ratio; CI, confidence interval; ETS, 
environmental tobacco smoke; Mi, myocardial infarction; hrT, hormone replacement therapy.
reported findings are consistent, it seems highly likely that 
the characteristics of patients with ACO differ from those of 
patients with asthma and COPD alone.
Determinants of aCO
HRT has previously been shown to be a risk factor for inci-
dent asthma in postmenopausal women,15,23–25 and in keeping 
with that, the present study showed that HRT was associated 
with a higher risk of both incident asthma and ACO (HR 
1.5 and 1.37, respectively). HRT was also associated with a 
higher risk of incident COPD (HR 1.24), possibly related to 
earlier menopause in female smokers, as also suggested by 
the large proportion of women with incident COPD on HRT 
at baseline (28.5%).
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Table 6 Determinants at baseline (1993–1997) of incident COPD at follow-up (2013) among 54,829 participants in the DCh cohort
Model 1, HR (95% CI) Model 2, HR (95% CI) Model 3, HR (95% CI)
age 50–54 years 1.00 1.00 –
age 55–59 years 1.10 (1.00–1.22) 0.87 (0.78–0.97) –
age 60–65 years 1.30 (1.16–1.46) 0.74 (0.66–0.84) –
Female 1.00 1.00 1.00
Male 1.01 (0.94–1.09) 0.73 (0.65–0.84) 0.73 (0.66–0.80)
never smoked 1.00 1.00 1.00
Previously smoked 3.34 (2.81–3.98) 1.09 (0.86–1.37) 1.22 (0.98–1.52)
Currently smoke 14.54 (12.46–16.96) 1.57 (1.20–2.06) 1.86 (1.44–2.40)
smoking duration (per 10 years) 1.96 (1.90–2.02) 1.59 (1.50–1.69) 1.52 (1.44–1.60)
smoking intensity (per 10 g/day) 1.50 (1.48–1.52) 1.18 (1.14–1.22) 1.19 (1.44–1.60)
no ETs 1.00 1.00 1.00
Exposed to ETs 4.50 (4.01–5.05) 1.21 (1.06–1.38) 1.21 (1.15–1.23)
no occupational exposure 1.00 1.00 1.00
had occupational exposures 1.78 (1.65–1.92) 1.27 (1.17–1.39) 1.29 (1.18–1.41)
Underweight (<18.5 kg/m2) 3.02 (2.34–3.89) 1.87 (1.45–2.41) 1.84 (1.43–2.37)
normal (18.5–25 kg/m2) 1.00 1.00 1.00
Overweight (25–30 kg/m2) 0.79 (0.73–0.86) 0.85 (0.78–0.92) 0.85 (0.78–0.92)
Obese (≥30 kg/m2) 1.00 (0.90–1.11) 1.04 (0.93–1.16) 1.04 (0.93–1.16)
inactive in leisure time 1.00 1.00 1.00
Physically active in leisure time 0.56 (0.52–0.60) 0.85 (0.78–0.92) 0.85 (0.79–0.92)
Fruit intake (100 g/day) 0.83 (0.81–0.86) 0.97 (0.95–1.00) 0.97 (0.94–1.00)
never used hrT 1.00 1.00 1.00
Ever used hrT 1.25 (1.15–1.36) 1.24 (1.13–1.37) 1.24 (1.13–1.38)
<8 years of education 1.00 1.00 1.00
8–10 years of education 0.62 (0.58–0.68) 0.85 (0.78–0.92) 0.85 (0.78–0.92)
≥10 years of education 0.44 (0.40–0.50) 0.77 (0.68–0.87) 0.77 (0.68–0.87)
Employed 1.00 1.00 1.00
Unemployed 1.73 (1.60–1.87) 1.27 (1.17–1.38) 1.22 (1.12–1.32)
single 1.11 (0.94–1.30) 1.00 (0.85–1.18) 1.01 (0.86–1.18)
Married 1.00 1.00 1.00
Divorced 1.70 (1.56–1.86) 1.27 (1.16–1.39) 1.28 (1.17–1.40)
Widowed 1.32 (1.15–1.53) 1.05 (0.91–1.21) 1.02 (0.88–1.18)
Comorbid conditions
no Mi 1.00 1.00 1.00
had Mi 2.16 (1.79–2.61) 1.46 (1.20–1.79) 1.49 (1.23–1.80)
no stroke 1.00 1.00 1.00
had stroke 2.32 (1.87–2.89) 1.54 (1.23–1.92) 1.54 (1.23–1.92)
no Diabetes 1.00 1.00 –
Diabetes 1.17 (0.91–1.49) 0.98 (0.77–1.26) –
no hypertension 1.00 1.00 1.00
hypertension 1.10 (1.00–1.21) 1.17 (1.06–1.29) 1.17 (1.06–1.29)
no hypercholesterolemia 1.00 1.00 –
hypercholesterolemia 1.26 (1.11–1.43) 1.07 (0.93–1.22) –
Notes: Model 1, univariate model; Model 2, fully adjusted model, with all variables in the model; Model 3, final model with determinants of asthma by stepwise selection 
(P<0.05). “–” indicates the variable not being included in model 3.
Abbreviations: COPD, chronic obstructive pulmonary disease; DCH, Danish Diet, Cancer, and Health; HR, hazard ratio; CI, confidence interval; ETS, environmental 
tobacco smoke; Mi, myocardial infarction; hrT, hormone replacement therapy.
In keeping with other studies,21,26,27 participants with inci-
dent ACO had a higher prevalence of comorbidity at baseline 
than participants with asthma and COPD alone, although 
this difference did not reach statistical significance in the 
fully adjusted model. However, this association persisted 
in the fully adjusted model for participants with incident 
COPD (HR 1.17, 1.49, and 1.54 for hypertension, MI, and 
stroke, respectively) and taken together, suggesting that the 
prevalence and impact of comorbidity in ACO are primarily 
driven by the COPD component of the disease.
In line with our findings, de Marco et al12 have previ-
ously reported a lower relative risk ratio (RRR) for ACO for 
people with higher education completed. The same was found 
for COPD, while the association was inversed for asthma 
(RRR 0.30, 0.38, and 1.61 for ACO, COPD, and asthma, 
respectively), similar to the findings in the present study. 
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Table 7 Determinants at baseline (1993–1997) of incident asthma at follow-up (2013) among 54,820 participants in the DCh cohort
Model 1, HR (95% CI) Model 2, HR (95% CI) Model 3, HR (95% CI)
age 50–54 years 1.00 1.00 –
age 55–59 years 0.92 (0.77–1.11) 0.89 (0.74–1.07) –
age 60–65 years 0.88 (0.70–1.10) 0.85 (0.67–1.08) –
Female 1.00 1.00 1.00
Male 0.67 (0.58–0.77) 0.86 (0.67–1.08) 0.79 (0.66–0.94)
never smoked 1.00 1.00 –
Previously smoked 0.93 (0.79–1.09) 1.07 (0.84–1.37) –
Currently smoke 0.52 (0.43–0.62) 1.03 (0.67–1.59) –
smoking duration (per 10 years) 0.86 (0.83–0.90) 0.96 (0.88–1.06) –
smoking intensity (per 10 g/day) 0.68 (0.61–0.75) 0.72 (0.60–0.87) –
no ETs 1.00 1.00 –
Exposed to ETs 0.77 (0.67–0.89) 0.97 (0.83–1.13) –
no occupational exposure 1.00 1.00 –
had occupational exposures 0.85 (0.71–1.01) 1.07 (0.89–1.30) –
Underweight (<18.5 kg/m2) 0.79 (0.29–2.12) 0.80 (0.30–2.15) 0.72 (0.27–1.94)
normal (18.5–25 kg/m2) 1.00 1.00 1.00
Overweight (25–30 kg/m2) 1.11 (0.95–1.30) 1.17 (1.00–1.37) 1.23 (1.05–1.44)
Obese (≥30 kg/m2) 1.37 (1.12–1.67) 1.38 (1.11–1.70) 1.52 (1.24–1.86)
inactive in leisure time 1.00 1.00 –
Physically active in leisure time 1.01 (0.88–1.16) 0.89 (0.77–1.03) –
Fruit intake (100 g/day) 1.04 (0.99–1.08) 0.99 (0.94–1.04) –
never used hrT 1.00 1.00 1.00
Ever used hrT 1.68 (1.45–1.95) 1.54 (1.29–1.84) 1.50 (1.26–1.80)
<8 years of education, 1.00 1.00 1.00
8–10 years of education 1.24 (1.05–1.47) 1.19 (1.01–1.42) 1.25 (1.06–1.47)
≥10 years of education 1.15 (0.94–1.41) 1.15 (0.93–1.43) 1.24 (1.02–1.52)
Employed 1.00 1.00 –
Unemployed 1.05 (0.88–1.24) 1.04 (0.87–1.25) –
single 0.95 (0.70–1.29) 0.97 (0.71–1.32) –
Married 1.00 1.00 –
Divorced 1.05 (0.87–1.27) 1.06 (0.88–1.29) –
Widowed 1.08 (0.80–1.46) 1.03 (0.75–1.40) –
Comorbid conditions 1.00 –
no Mi 1.00 1.00 –
had Mi 0.93 (0.54–1.61) 1.14 (0.65–2.01) –
no stroke 1.00 1.00 –
had stroke 0.42 (0.16–1.13) 0.46 (0.17–1.23) –
no diabetes 1.00 1.00 –
Diabetes 0.89 (0.51–1.54) 0.89 (0.51–1.55) –
no hypertension 1.00 1.00 –
hypertension 1.30 (1.09–1.55) 1.21 (1.01–1.45) –
no hypercholesterolemia 1.00 1.00 –
hypercholesterolemia 0.79 (0.59–1.07) 0.78 (0.57–1.06) –
Notes: Model 1, univariate model; Model 2, fully adjusted model, with all variables in the model; Model 3, final model with determinants of asthma by stepwise selection 
(P<0.05). “–” indicates the variable not being included in model 3. 
Abbreviations: DCH, Danish Diet, Cancer, and Health; HR, hazard ratio; CI, confidence interval; ETS, environmental tobacco smoke; MI, myocardial infarction; HRT, 
hormone replacement therapy.
In  contrast, Ekerljung et al28 found no associating between 
length of education and either of the three groups of patients 
with obstructive lung disease in their adjusted analyses.
Our study revealed, to our knowledge not previously 
reported, that being divorced was a strong determinant of 
incident ACO (HR 1.52) and also a determinant of incident 
COPD (HR 1.28). Furthermore, being widowed was also 
associated with a higher risk of incident ACO (HR 1.53). 
The explanation for these findings related to marital status 
may be that it reflects social network and status, including 
not having someone at close hand to look out for you, eg, in 
relation to smoking cessation. In line with this, unemploy-
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Table 8 Determinants at baseline (1993–1997) of incident asthma, COPD, or aCO at follow-up (2013) among 55,500 participants in 
the DCh cohort
Asthma, HR (95% CI) COPD, HR (95% CI) ACO, HR (95% CI)
age 50–54 years – – 1.00
age 55–59 years – – 2.11 (1.65–2.71)
age 60–65 years – – 4.41 (3.33–5.85)
Female 1.00 1.00 1.00
Male 0.79 (0.66–0.94) 0.73 (0.66–0.80) 0.83 (0.67–1.03)
never smoked – 1.00 1.00
Previously smoked – 1.22 (0.98–1.52) 2.23 (1.70–2.92)
Currently smoke – 1.86 (1.44–2.40) 3.59 (2.81–4.59)
smoking duration (per 10 years) – 1.52 (1.44–1.60) –
smoking intensity (per 10 g/day) – 1.19 (1.44–1.60) –
no ETs – 1.00 –
Exposed to ETs – 1.21 (1.15–1.23) –
no occupational exposure . 1.00 –
had occupational exposures – 1.29 (1.18–1.41) –
Underweight (<18.5 kg/m2) 0.72 (0.27–1.94) 1.84 (1.43–2.37) 1.76 (0.96–3.24)
normal (18.5–25 kg/m2) 1.00 1.00 1.00
Overweight (25–30 kg/m2) 1.23 (1.05–1.44) 0.85 (0.78–0.92) 1.04 (0.86–1.26)
Obese (≥30 kg/m2) 1.52 (1.24–1.86) 1.04 (0.93–1.16) 1.20 (0.94–1.54)
inactive in leisure time – 1.00 1.00
Physically active in leisure time – 0.85 (0.79–0.92) 0.66 (0.55–0.78)
Fruit intake (100 g/day) – 0.97 (0.94–1.00) –
never used hrT 1.00 1.00 1.00
Ever used hrT 1.50 (1.26–1.80) 1.24 (1.13–1.38) 1.37 (1.11–1.70)
<8 years of education 1.00 1.00 1.00
8–10 years of education 1.25 (1.06–1.47) 0.85 (0.78–0.92) 0.84 (0.70–1.01)
≥10 years of education 1.24 (1.02–1.52) 0.77 (0.68–0.87) 0.67 (0.51–0.87)
Employed – 1.00 1.00
Unemployed – 1.22 (1.12–1.32) 1.48 (1.23–1.79)
single – 1.01 (0.86–1.18) 0.81 (0.53–1.22)
Married – 1.00 1.00
Divorced – 1.28 (1.17–1.40) 1.52 (1.24–1.85)
Widowed – 1.02 (0.88–1.18) 1.53 (1.14–2.05)
Comorbid conditions – – –
no Mi – 1.00 –
had Mi – 1.49 (1.23–1.80) –
no stroke – 1.00 –
had stroke – 1.54 (1.23–1.92) –
no diabetes – – –
Diabetes – – –
no hypertension – 1.00 –
hypertension – 1.17 (1.06–1.29) –
no hypercholesterolemia – – –
hypercholesterolemia – 0.78 (0.57–1.06) –
Notes: HR are from stepwise selection of all variables statistically significant (P<0.05) in the fully adjusted model. “–” indicates the variable not being included in model 3.
Abbreviations: COPD, chronic obstructive pulmonary disease; aCO, asthma–chronic obstructive pulmonary disease overlap; DCh, Danish Diet, Cancer, and health; hr, 
hazard ratio; CI, confidence interval; ETS, environmental tobacco smoke; MI, myocardial infarction; HRT, hormone replacement therapy.
ment was also associated with a significant higher HR for 
ACO (HR 1.48) and also for COPD (HR 1.22), probably also 
reflecting socioeconomic status.
With regard to tobacco exposure, both current and for-
mer smokers had a higher HR for ACO (HR 3.59 and 2.23, 
respectively), and likewise, we found that current smokers 
had a higher HR for incident COPD, probably also primarily 
a marker of lower socioeconomic status.29 In a study pub-
lished in 2013, de Marco et al12 found the RRR for smoking 
status to be higher for COPD (3.1 and 1.56, respectively, for 
current and former smokers) than for ACO (1.79 and 1.56, 
respectively), but, in contrast to our results, also a higher 
RRR for asthma (1.27). Ekerljung et al28 found the association 
between smoking and ACO to be statistically significant only 
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for individuals with lifetime tobacco exposure of >20 pack-
years (odds ratio [OR] 3.01) and found no difference in OR 
between ACO and COPD. Taken together, these findings 
therefore further support the notion that ACO is linked to 
markers of socioeconomic status.
limitations
This being a register-based study means that we unfortunately 
had no access to information on change of risk behavior, 
including smoking habits, clinical findings, and informa-
tion about prescribed medication and filled prescriptions, all 
factors that may have improved the characterization of the 
participants in our cohort. However, the attending physicians 
have had access to the individual disease manifestations, ie, 
symptoms, and clinical and para-clinical findings. The valid-
ity of discharge diagnoses in the DNPR has been assessed 
for both COPD30 and asthma,31 giving us confidence that 
the registered diagnoses are reliable.32 Another limitation of 
our study is that since we have only included patients with 
hospital contacts for asthma and/or COPD, we are likely to 
have excluded patients with milder diseases, as these are often 
diagnosed and followed solely by their general practitioner.
Conclusion and future perspectives
Our study has revealed that incident ACO is to a large extent 
determined by factors related to lifestyle and socioeconomic 
status, and by that, we have pinpointed areas that are likely to 
be important for assessing risk of ACO in individuals evalu-
ated for possible obstructive airways disease. Furthermore, 
as lower socioeconomic status and less healthy lifestyle 
are likely to have negative impact on long-term outcome 
of obstructive airways diseases; our observations may also 
provide guidance to identify a vulnerable group of high-risk 
patients. Another important aspect of identifying patients 
with ACO is the ongoing debate of positioning of treatment 
with inhaled corticosteroid for COPD, as patients with an 
asthma component of their obstructive airways disease are 
likely to benefit substantially from anti-inflammatory therapy.
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